Ellie White, 10, of Colorado, has been diagnosed three years ago with a rare genetic illness that will soon leave her blind and deaf, but before that happens, the little girl is determined to live life to the fullest.
Sarah Syvertsen of Arbor Heights e-mailed WSB to share the news about her brand-new business, Rylee’s Pocket. She and her aunt are “making tank tops for kids and adults with type 1 diabetes that have a special pocket to hold their insulin pumps.
Not Just a Conference - A Call to Action BOSTON, July 18, 2012 /PRNewswire/ -- The diabetes epidemic demands a powerful response from leaders in the diabetes community, nationally and globally. To this end, for the first time in its 114 year history, Joslin Diabetes Center, an affiliate of Harvard Medical School will convene all stakeholders for a groundbreaking, immersive activity over 3 days in September called Diabetes Innovation 2012 (September 23-25, 2012 at the Hyatt Crystal City in Arlington, VA). Diabetes Innovation 2012 will act as a powerful catalyst for ideas, partnerships and collaborations. It will provoke thought, innovation and action that address the cost, productivity and quality-of-life impact of diabetes on our society by bringing together all stakeholders: payers, purchasers, providers, industry, government, research, patients, consumers, technologists, developers, and funders. "Simply put, we MUST forge new approaches and dramatically increase our sense of urgency to address diabetes head-on. Despite all of our collective efforts, we are not keeping up with the global threats presented by obesity and diabetes," says John L. Brooks III, CEO, Joslin Diabetes Center. "To effectively make a real difference, we need to convene, apply our collective energies, and work together, to truly create innovative policies and programs that will involve all stakeholders and that will make a real difference. This world-wide pandemic will not be solved until all of us use our combined resources, commitment, determination, and passion to map out an aggressive and meaningful path forward."
Johnson & Johnson's (JNJ) LifeScan unit has acquired a closely held developer of a wearable insulin patch for people with diabetes.
LifeScan acquired Calibra Medical Inc., of Redwood City, Calif., on July 13, said LifeScan spokesman Dave Detmers.
Financial terms aren't being disclosed. The insulin patch isn't available yet, and LifeScan isn't saying when it expects it to become available. The product must meet "a number of milestones" before it reaches market.
Research collaboration to explore novel target shown in pre-clinical studies to play significant role in type 1 diabetes
BOSTON, July 18, 2012 /PRNewswire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) today announced a new research collaboration with Brigham and Women’s Hospital (BWH), a teaching and research affiliate of Harvard Medical School, focused on immunology of type 1 diabetes. The two organizations will share knowledge and apply their respective expertise in basic and applied research regarding diabetes and drug target and candidate development.
DIABETES WA is highlighting the need for better stress management for people who live with diabetes.
Type 1 and type 2 diabetes affect over a million Australians and the number of people diagnosed with type 2 diabetes is expected to triple in just over ten years.
Results from the Diabetes MILES Study, released in May by Diabetes Australia, indicate that about one in four people with diabetes experience clinical levels of depression.
The study, which examined over 3300 Australians with diabetes, found that adults with type 2 insulin-treated diabetes experience the highest levels of depression and anxiety with 35 per cent experiencing moderate to severe depressive symptoms.
Severe diabetes-related distress is more common in adults with type 1 diabetes, with 28 per cent experiencing signs of severe distress.
The Australian Centre for Behavioural Research in Diabetes foundation director Professor Jane Speight, who conducted the study, says people with type 1 diabetes were more likely to feel distressed because they had lived with the condition for much longer and the demands of managing their condition, which involved daily injections and blood checks, were exhausting.
“There is no holiday from type 1 diabetes,” Prof Speight says.
“Prof Speight says fluctuating blood glucose levels induced by stress could lead to severe hypoglycaemia in the short-term and other serious long-term complications....
I’m about as frustrated as a person with diabetes can be. Last night my insulin pump started to flash “BUTTON ERROR” and beep every few minutes. It took a few minutes for me to realize the problem wasn’t going away.
OBJECTIVE Even under closed-loop (CL) conditions, meal-related blood glucose (BG) excursions frequently exceed target levels as a result of delays in absorption of insulin from the subcutaneous site of infusion. We hypothesized that delaying gastric emptying with preprandial injections of pramlintide would improve postprandial glycemia by allowing a better match between carbohydrate and insulin absorptions.RESEARCH DESIGN AND METHODSEight subjects (4 female; age, 15-28 years; A1C, 7.5 ± 0.7%) were studied for 48 h on a CL insulin-delivery system with a proportional integral derivative algorithm with insulin feedback: 24 h on CL control alone (CL) and 24 h on CL control plus 30-μg premeal injections of pramlintide (CLP). Target glucose was set at 120 mg/dL; timing and contents of meals were identical on both study days. No premeal manual boluses were given. Differences in reference BG excursions, defined as the incremental glucose rise from premeal to peak, were compared between conditions for each meal.RESULTSCLP was associated with overall delayed time to peak BG (2.5 ± 0.9 vs. 1.5 ± 0.5 h; P < 0.0001) and reduced magnitude of glycemic excursion (88 ± 42 vs. 113 ± 32 mg/dL; P = 0.006) compared with CL alone. Pramlintide effects on glycemic excursions were particularly evident at lunch and dinner, in association with higher premeal insulin concentrations at those mealtimes.CONCLUSIONSPramlintide delayed the time to peak postprandial BG and reduced the magnitude of prandial BG excursions. Beneficial effects of pramlintide on CL may in part be related to higher premeal insulin levels at lunch and dinner compared with breakfast.
I have long complained about the Medtronic Continuous Glucose Monitor (CGM), but for a little while, I had made peace with the sucker because I had entered some sort of CGM zen in which I could use a single sensor for two weeks, and in a couple of cases, nearly a month. It was amazing. Two boxes lasted so long that the last few actually expired. With longevity like that, I could overlook the inaccuracies and idiosyncrasies of the Medtronic sensor as compared to the Dexcom. It hurts like hell, but if I only need to harpoon myself once every three weeks, whatever! But then it stopped. Two boxes of magic sensors, and now I can get maybe 7 days, if I’m lucky. Back to where I started. ....
SAN DIEGO and EDMONTON, Alberta, July 19, 2012 -- /PRNewswire/ -- Conatus Pharmaceuticals Inc. and the University of Alberta announced today the treatment of the first patient in an investigator-initiated islet cell transplant Phase I/II trial of emricasan (IDN-6556), a pan-caspase inhibitor. The objective of the trial is to determine safety, achievement and maintenance of insulin independence and to obtain preliminary data on the efficacy of emricasan to maintain adequate immunological protection against both allo- and autoimmunity of islet cell transplant recipients. The sponsor of the trial is the University of Alberta and the principal investigator is A. M. James Shapiro, M.D., Ph.D.
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for the Accu-Chek Combo system for insulin pump therapy.
The Goals The goals of the NPA and its National Stakeholder Strategy for Achieving Health Equity are: Awareness - Increase awareness of the significance of health disparities, their impact on the nation, and the actions necessary to improve health outcomes for racial, ethnic, and underserved populations. Leadership - Strengthen and broaden leadership for addressing health disparities at all levels. Health System and Life Experience - Improve health and healthcare outcomes for racial, ethnic, and underserved populations. Cultural and Linguistic Competency - Improve cultural and linguistic competency and the diversity of the health-related workforce. Data, Research, and Evaluation - Improve data availability and coordination, utilization, and diffusion of research and evaluation outcomes.
To say that her son has benefited from living with an incurable disease isn't quite how Fondra Magee would put it. More accurate would be that type 1 diabetes has brought out courage and creativity in Carson, that it has placed him in the roles of spokesperson, do-gooder and even inventor.
“Bakery is chemistry—gluten-free baking is really a science,” says gluten-intolerant baker and blogger Rella Kaplowitz of pennypinchingepicure.com.
Kaplowitz began experimenting with gluten-free cooking to deal with frequent stomachaches. She went back on gluten for a few months so that she could be tested for celiac disease. Although that test came up negative, she’s adopted gluten-free eating to deal with her gluten intolerance.
Kaplowitz’s first few forays into baking without gluten yielded some disappointing results. The muffins were “so hard and dense, they went right into the garbage,” she says. Undaunted, Kaplowitz put on her lab apron and started to experiment.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.